Search Results




Item Results : 1-20 of 50.

NO Title , Author(s) , Publication , Issue Date
1 Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer / S R Lee; Y G Roh; Seon-Kyu Kim; J S Lee; S Y Seol; H H Lee; W T Kim; W J Kim; J Heo; H J Cha; T H Kang; J W Chung; In-Sun Chu; S H Leem , 2015
2 ADGO: analysis of differentially expressed gene sets using composite GO annotation / Dougu Nam; Sang-Bae Kim; Seon-Kyu Kim; Sungjin Yang; Seon-Young Kim; In-Sun Chu , 2006
3 The anticancer effects of garlic extracts on bladder cancer compared to cisplatin: a common mechanism of action via centromere protein M / W T Kim; S P Seo; Y J Byun; H W Kang; Y J Kim; S C Lee; P Jeong; H J Song; S Y Choe; D J Kim; Seon-Kyu Kim; Y S Ha; S K Moon; G T Lee; I Y Kim; S J Yun; W J Kim , 2018
4 APPEX: analysis platform for the identification of prognostic gene expression signatures in cancer / Seon Kyu Kim; Jong Hwan Kim; S J Yoon; W J Kim; Seon-Young Kim , 2014
5 Beyond chemical triggers : evidence for sound-evoked physiological reactions in plants / Jihye Jung; Seon-Kyu Kim; J Y Kim; M J Jeong; Choong-Min Ryu , 2018  
6 Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer / Bic Na Song; Seon-Kyu Kim; In-Sun Chu , 2017  
7 Biological characteristics and clinical significance of ITGB1 and RHOC in patients with recurrent colorectal cancer / Y J Ha; K H Tak; Seon-Kyu Kim; C W Kim; J L Lee; S A Roh; D H Cho; Seon-Young Kim; Yong Sung Kim; J C Kim , 2019
8 Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression / Yu-Seon Kang; Eun-Jeong Jung; Hyun-Jeong Seok; Seon-Kyu Kim; Jin-Seong Hwang; M L Choi; D G Jo; Yuna Kim; Jinhyeon Choi; Yeo Jin Lee; Eunsun Jung; Jeong Ki Min; Tae Su Han; Jang Seong Kim , 2019
9 Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer / J L Lee; S A Roh; C W Kim; Y H Kwon; Y J Ha; Seon-Kyu Kim; Seon-Young Kim; D H Cho; Yong Sung Kim; J C Kim , 2019
10 The c-MET network as novel prognostic marker for predicting bladder cancer patients with an increased risk of developing aggressive disease / Y W Kim; S J Yun; P Jeong; Seon-Kyu Kim; Seon-Young Kim; C Yan; S P Seo; S K Lee; J Kim; W J Kim , 2015  
11 c-MYC drives breast cancer metastasis to the brain, but promotes synthetic lethality with TRAIL / H Y Lee; J Cha; Seon-Kyu Kim; J H Park; K H Song; P Kim; M Y Kim , 2019
12 Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: Quantitative pyrosequencing analysis / H Y Yoon; Seon-Kyu Kim; Y W Kim; H W Kang; S C Lee; K H Ryu; H S Shon; W J Kim; Y J Kim , 2012
13 Complex behavior of ALDH1A1 and IGFBP1 in liver metastasis from a colorectal cancer / J C Kim; Y J Ha; K H Tak; S A Roh; C W Kim; T W Kim; Seon-Kyu Kim; Seon-Young Kim; D H Cho; Yong Sung Kim , 2016  
14 A database of gene expression profiles of Korean cancer genome / Seon-Kyu Kim; In-Sun Chu , 2015
15 Differential matrix metalloprotease (MMP) expression profiles found in aged gingiva / S Kim; S H Ahn; J S Lee; J E Song; S H Cho; S Jung; Seon-Kyu Kim; Seok Ho Kim; Kwang-Pyo Lee; Ki Sun Kwon; T H Lee , 2016  
16 Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors / M R Yun; S M Lim; Seon-Kyu Kim; H M Choi; K H Pyo; S K Kim; J M Lee; Y W Lee; J W Choi; H R Kim; M H Hong; Keeok Haam; Nanhyung Huh; Jong Hwan Kim; Yong Sung Kim; H S Shim; R A Soo; J Y Shih; J C H Yang; Mirang Kim; B C Cho , 2018
17 Exploring the sound-modulated delay in tomato ripening through expression analysis of coding and non-coding RNAs / J Y Kim; Seon-Kyu Kim; Jihye Jung; M J Jeong; Choong-Min Ryu , 2018
18 Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors / J S Lee; Sun Hee Leem; Sang-Yeop Lee; S C Kim; E S Park; S B Kim; Seon-Kyu Kim; Y J Kim; W J Kim; In-Sun Chu , 2010
19 Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer / Seon Kyu Kim; Y G Roh; Kiejung Park; T H Kang; W J Kim; J S Lee; S H Leem; In-Sun Chu , 2014
20 Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer / S A Roh; I J Park; Y S Yoon; Y H Kwon; J H Chung; T W Kim; D H Cho; Byung Ho Lim; Seon-Kyu Kim; Seon-Young Kim; Yong Sung Kim; J C Kim , 2016


DSpace Software Coptright(c) 2010 MIT and Hewleft-Packard  /  KRIBB-REPOSITORY (